01 2Dymista
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 180
2021 Revenue in Millions : 168
Growth (%) : 7
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 200
2022 Revenue in Millions : 180
Growth (%) : 11
LOOKING FOR A SUPPLIER?